Open Accessibility Menu

PGY-2 Critical Care Pharmacy Residency Program

Swedish Sponsored Fellowship Programs

747 Broadway Seattle, WA 98122

PGY-2 Critical Care Pharmacy Residency Program

PGY2 residency programs build upon Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency training to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives for advanced practice areas. Residents who successfully complete PGY2 residency programs are prepared for advanced patient care or other specialized positions, and board certification in the advanced practice area, if available.

Swedish Medical Center’s ASHP-accredited PGY2 Critical Care Pharmacy Residency Program has been training the next generation of critical care pharmacy leaders since 2020. Our mission is to create an environment for residents to master critical care pharmacotherapy, develop their own progressive practice, and lead the profession forward through innovation, education, and collaboration. We want our residents to feel both challenged and supported as they take ownership of their growth and aspirations. Training at a community health system within Washington State affords our residents the opportunity to practice autonomously at the top of their license as an essential stakeholder within the healthcare team. We currently offer 1 PGY2 critical care pharmacy resident position.

Requirements for Successful Program Completion

  1. Obtain a Washington State pharmacist license within the first 90 days of the program
  2. Maintain Advanced Cardiac Life Support (ACLS) Pediatric Advanced Life Support (PALS), and Neonatal Resuscitation Program (NRP) certifications for the duration of the program
  3. Complete all required rotation learning experiences: Orientation, Surgical Intensive Care, Neuro Critical Care, Cardiac Intensive Care, Neonatal and Pediatric Intensive Care, Medical Intensive Care, and Emergency Medicine
  4. Complete 2 elective rotation learning experiences
  5. Complete all required longitudinal learning experiences: Longitudinal Research Project, Medication Use Evaluation, Drug Class Review, and Staffing
  6. Active participation in all assigned committees: Residency Advisory Committee, Residency Interview Committee, Critical Care Council, and Pulmonary Embolism Response Team Committee
  7. Reach Achieved for Residency for at least 80% of objectives with no objectives marked as Needs Improvement
  8. Complete all required presentations: American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting longitudinal research project poster presentation, Western States Conference longitudinal research project presentation, and a Continuing Pharmacy Education presentation
  9. Complete manuscript for longitudinal research project suitable for publication in a critical care- or pharmacy-focused journal
  10. Complete all required documentation: initial assessment and quarterly development plans, learning experience and preceptor evaluations, duty hour attestations, and the required disease states spreadsheet

Application Process

We sincerely welcome all applicants who meet the criteria below, regardless of race, ethnicity, disability, gender identity or expression, sexual orientation, socioeconomic status, religion, or age. Please note that we are unable to sponsor Green Cards or Visas at this time.

  • Graduation from an ACPE-accredited pharmacy school
  • Completion of an ASHP-accredited PGY1 residency program (or program undergoing accreditation process)
  • Ability to work in the United States
  • Eligibility for Washington State pharmacist licensure
  • Submission of application in PhORCAS by January 2, at 11:59PM PST, including
    • Curriculum vitae
    • One-page letter of intent addressed to the Residency Interview Committee
    • Three letters of recommendation.